Other potential biomarkers of early HCC include heat shock protein 70 (HSP70), cyclase-associated protein 2 (CAP2), glypican-3 (GPC3), glutamine synthetase (GS), and Golgi protein 73 (GP73), but none has been clinically approved to date49–52. This evidence concerns the gene GPC3 and hepatocellular carcinoma.